|
| 36470531 | Rivaroxaban in patients with symptomatic peripheral artery disease after lower extremity bypass surgery with venous and prosthetic conduits. | J Vasc Surg | 2023 |
| 36175645 | The association of maternal sugary beverage consumption during pregnancy and the early years with childhood sugary beverage consumption. | Canadian Journal of Public Health | 2023 |
| 36444513 | Health status and cognitive function for risk stratification in chronic coronary and peripheral artery disease. | Eur J Prev Cardiol | 2023 |
| 37734401 | Glocal is global: reimagining the training of global health students in high-income countries. | | 2023 |
| 37908396 | Association between impaired lung function and carotid intima-media thickness in children. | | 2023 |
| 37768908 | Strengthening Community Roots: Anchoring Newcomers in Wellness and Sustainability (SCORE!): A protocol for the co-design and evaluation of a healthy active living program among a newcomer community in Canada. | | 2023 |
| 37158942 | Early sex-dependent differences in metabolic profiles of overweight and adiposity in young children: a cross-sectional analysis. | | 2023 |
| 37034649 | Multi-ancestry genome-wide study in >2.5 million individuals reveals heterogeneity in mechanistic pathways of type 2 diabetes and complications. | medRxiv | 2023 |
| 37080912 | Dietary intake and cardiovascular outcomes in patients with chronic vascular disease: insights from the COMPASS trial cohort. | Eur J Prev Cardiol | 2023 |
| 37023507 | The predictive value of interarm systolic blood pressure differences in patients with vascular disease: Sub-analysis of the COMPASS trial. | | 2023 |
| 36894240 | The Relationship Between Diet, Gut Microbiota, and Serum Metabolome of South Asian Infants at 1 Year. | | 2023 |
| 37332914 | Integrative multiomics analysis of infant gut microbiome and serum metabolome reveals key molecular biomarkers of early onset childhood obesity. | | 2023 |
| 37015794 | Perceptions of COVID-19 risk, vaccine access and confidence: a qualitative description of South Asians in Canada. | | 2023 |
| 36702047 | Changes in energy, macronutrient, and food consumption in 47 countries over the last 70 years (1950-2019): a systematic review and meta-analysis. | | 2023 |
| 37130668 | A culturally tailored personaliseD nutrition intErvention in South ASIan women at risk of Gestational Diabetes Mellitus (DESI-GDM): a randomised controlled trial protocol. | | 2023 |
| 34871861 | Non-esterified fatty acids as biomarkers of diet and glucose homeostasis in pregnancy: The impact of fatty acid reporting methods: NEFA reporting methods affect dietary and cardiometabolic endpoints. | | 2022 |
| 36251249 | Efficacy and safety of rivaroxaban versus placebo after lower extremity bypass surgery: A post hoc analysis of a "CASPAR like" outcome from VOYAGER PAD. | Clin Cardiol | 2022 |
| 35594542 | Patients selected for dual pathway inhibition in clinical practice have similar characteristics and outcomes to those included in the COMPASS randomized trial: The XATOA Registry. | Eur Heart J Cardiovasc Pharmacother | 2022 |
| 35393509 | Identification of genetic effects underlying type 2 diabetes in South Asian and European populations. | Commun Biol | 2022 |
| 36368751 | Barriers and facilitators to healthy active living in South Asian families in Canada: a thematic analysis. | BMJ Open | 2022 |
| 35513483 | Author Correction: Identification of genetic effects underlying type 2 diabetes in South Asian and European populations. | Commun Biol | 2022 |
| 35450870 | Serum metabolomic signatures of gestational diabetes in South Asian and white European women. | BMJ Open Diabetes Research and Care | 2022 |
| 36228641 | Colchicine and the combination of rivaroxaban and aspirin in patients hospitalised with COVID-19 (ACT): an open-label, factorial, randomised, controlled trial. | Lancet Respir Med | 2022 |
| 36228639 | Colchicine and aspirin in community patients with COVID-19 (ACT): an open-label, factorial, randomised, controlled trial. | Lancet Respir Med | 2022 |
| 35699170 | Sex-Based Differences in Outcomes Following Peripheral Artery Revascularization: Insights From VOYAGER PAD. | J Am Heart Assoc | 2022 |
| 35383832 | Long-Term Treatment with the Combination of Rivaroxaban and Aspirin in Patients with Chronic Coronary or Peripheral Artery Disease: Outcomes During the Open Label Extension of the COMPASS trial. | Eur Heart J Cardiovasc Pharmacother | 2022 |
| 36088949 | Metabolic, behavioural, and psychosocial risk factors and cardiovascular disease in women compared with men in 21 high-income, middle-income, and low-income countries: an analysis of the PURE study. | Lancet, The | 2022 |
| 36153036 | South Asian Youth as Vaccine Agents of Change (SAY-VAC): evaluation of a public health programme to mobilise and empower South Asian youth to foster COVID-19 vaccine-related evidence-based dialogue in the Greater Toronto and Hamilton Area, Canada. | BMJ Open | 2022 |
| 35565704 | Impact of Maternal Health Behaviours and Social Conditions on Infant Diet at Age 1-Year: Results from a Prospective Indigenous Birth Cohort in Ontario, Canada. | Nutrients | 2022 |
| 35745237 | Sources of Variation in Food-Related Metabolites during Pregnancy. | Nutrients | 2022 |
| 35551307 | Multi-ancestry genetic study of type 2 diabetes highlights the power of diverse populations for discovery and translation. | Nat Genet | 2022 |
| 35731517 | Rivaroxaban and Risk of Venous Thromboembolism in Patients With Symptomatic Peripheral Artery Disease After Lower Extremity Revascularization. | JAMA Netw Open | 2022 |
| 35790229 | Seropositivity and risk factors for SARS-CoV-2 infection in a South Asian community in Ontario: a cross-sectional analysis of a prospective cohort study. | CMAJ open | 2022 |
| 35537813 | Canadian Cardiovascular Society 2022 Guidelines for Peripheral Arterial Disease. | Canadian Journal of Cardiology | 2022 |
| 36412575 | The genetic risk of gestational diabetes in South Asian women. | Elife | 2022 |
| 35718241 | A Call to Action: Optimizing Indigenous Cardiovascular Health in Canada. | Can J Cardiol | 2022 |
| 35534928 | Microvascular disease increases the risk of lower limb amputation - A Western Danish cohort study. | European Journal of Clinical Investigation | 2022 |
| 35467452 | Improvement in walking impairment following surgical and endovascular revascularization: Insights from VOYAGER PAD. | Vasc Med | 2022 |
| 36962630 | Use of race, ethnicity, and ancestry data in health research. | | 2022 |
| 36505380 | Insight into genetic, biological, and environmental determinants of sexual-dimorphism in type 2 diabetes and glucose-related traits. | | 2022 |
| 36600330 | Effects of lifestyle interventions on cardiovascular risk factors in South Asians: a systematic review and meta-analysis. | | 2022 |
| 34191011 | Low-dose rivaroxaban plus aspirin in patients with polypharmacy and multimorbidity: an analysis from the COMPASS trial. | Eur Heart J Cardiovasc Pharmacother | 2022 |
| 34463737 | Low-dose rivaroxaban and aspirin among patients with peripheral artery disease: a meta-analysis of the COMPASS and VOYAGER trials. | Eur J Prev Cardiol | 2022 |
| 35043716 | Rivaroxaban with Aspirin Versus Aspirin for Peripheral Arterial Disease and Intermittent Claudication. Rationale and Design of the COMPASS CLAUDICATION Trial. | Clin Appl Thromb Hemost | 2022 |
| 35307328 | Diet and Nutrition in Peripheral Artery Disease: A Systematic Review. | Canadian Journal of Cardiology | 2022 |
| 34980185 | Normal sex and age-specific parameters in a multi-ethnic population: a cardiovascular magnetic resonance study of the Canadian Alliance for Healthy Hearts and Minds cohort. | J Cardiovasc Magn Reson | 2022 |
| 35252829 | The Anti-Coronavirus Therapies (ACT) Trials: Design, Baseline Characteristics, and Challenges. | CJC Open | 2022 |
| 34971734 | Social Deprivation and Peripheral Artery Disease. | Canadian Journal of Cardiology | 2022 |
| 35231554 | Antithrombotic Therapy in Peripheral Artery Disease: Risk Stratification and Clinical Decision Making. | Canadian Journal of Cardiology | 2022 |
| 35170216 | Prevention of arterial and venous thrombotic events in symptomatic peripheral arterial disease patients after lower extremity revascularization in the VOYAGER PAD trial: Dual anticoagulant/antiplatelet regimen vs antiplatelet therapy alone. | J Thromb Haemost | 2022 |